Develops tissue-specific gene therapies that use transient partial cellular reprogramming to treat Alzheimer's and other brain diseases.
Epigenetic reprogramming biotech using transcription factors to restore youthful gene expression in aging cells, starting with the liver.
Including Funding rounds + valuations, Founders + executives, Products + tech stack, Headcount + HQ, Status timeline, and Roster connections.
Already subscribed? Sign in →